How Long Does Bravecto Last? Understanding 12-Week Flea and Tick Protection
Bravecto (Fluralaner) is an isoxazoline-class systemic ectoparasiticide indicated for the treatment and prevention of flea and tick infestations in dogs and cats. Each chewable tablet or topical dose provides up to 12 full weeks of continuous protection (with specific 8-week exceptions for certain tick species like the lone star tick in select regions). Medications in the isoxazoline class should be used with caution in dogs with a history of seizures or neurologic disorders. Always calculate dosage strictly by your pet’s current body weight under veterinary direction. This guide serves strictly educational purposes.
Fleas and ticks are more than just an itch-inducing nuisance—they serve as vectors for dangerous pathogens, including Borrelia burgdorferi (Lyme disease), Rickettsia, Ehrlichia, and flea tapeworms (Dipylidium caninum). Traditional monthly topicals and oral chews require frequent re-administration, which often leads to compliance gaps and re-infestation.
**Bravecto** transformed parasite prevention by introducing a long-acting systemic solution that provides **12 weeks (nearly 3 months) of continuous protection** in a single oral chew or topical application.
Understanding how Bravecto maintains efficacy for nearly three times longer than traditional monthly treatments requires examining its active compound (Fluralaner), its mechanism of action, species-specific duration boundaries, weight-tiered dosing selections, and key safety parameters.
Why Does Bravecto Last 12 Weeks? The Science of Fluralaner
The extended duration of Bravecto stems from the unique pharmacokinetic properties of **Fluralaner**, a potent member of the isoxazoline class of ectoparasiticides:
How Fluralaner Maintains Prolonged Efficacy
1. Rapid Absorption & Tissue Binding: Following oral ingestion with food, Fluralaner is rapidly absorbed into the bloodstream and binds strongly to plasma proteins. This protein binding creates a long-lasting systemic reservoir throughout the dog’s tissues and hair follicles.
2. Slow Elimination Half-Life: Fluralaner exhibits a remarkably long elimination half-life (12 to 15 days in dogs). It is slowly metabolized and cleared primarily through hepatic and biliary excretion into the feces, maintaining therapeutic plasma levels above the minimum lethal concentration for fleas and ticks for 84 full days.
3. Dual-Channel Neuromuscular Blockade: When fleas and ticks attach and take a blood meal, they ingest Fluralaner. The compound selectively inhibits arthropod $\gamma$-aminobutyric acid (GABA)-gated and L-glutamate-gated chloride channels. This blocks inhibitory nerve signaling, causing hyperexcitation, paralysis, and rapid parasite death before viable flea eggs can be laid.
Kill Speeds & Tick Duration Boundaries
Bravecto begins working rapidly once ingested, breaking the flea life cycle before reproduction can occur:
- Flea Onset & Duration: Begins killing adult fleas within 2 hours of attachment and eliminates >98% of fleas within 12 hours, maintaining continuous flea control for a full 12 weeks.
- Black-Legged, American Dog, & Brown Dog Ticks: Provides 12 weeks of sustained kill efficacy against Ixodes scapularis, Dermacentor variabilis, and Rhipicephalus sanguineus.
- Lone Star Tick Exception (Amblyomma americanum): In geographic areas where lone star ticks are prevalent, Bravecto provides robust protection for 8 weeks rather than 12 weeks for this specific species.
Choosing the Correct Strength by Weight Tier
To ensure consistent 12-week therapeutic plasma concentrations, Bravecto is formulated in specific milligram tiers based on the target minimum dosage of **25 mg Fluralaner per kg (11.4 mg/lb) of body weight**:
| Weight Range (kg / lbs) | Chewable Tablet Strength | Target Patient Profile |
|---|---|---|
| 2.0 – 4.5 kg (4.4 – 9.9 lbs) |
Bravecto 112.5 Mg (2 Kg – 4.5 Kg) | Toy and miniature breeds, small puppies (≥6 months of age). |
| 10.0 – 20.0 kg (22.0 – 44.0 lbs) |
Bravecto 500 Mg (10 Kg – 20 Kg) | Medium dog breeds (e.g., Beagles, Cocker Spaniels, French Bulldogs). |
| 20.0 – 40.0 kg (44.0 – 88.0 lbs) |
Bravecto 1000 Mg (20-40 kg) | Large dog breeds (e.g., Golden Retrievers, German Shepherds, Labradors). |
| 40.0 – 56.0 kg (88.0 – 123.0 lbs) |
Bravecto 1400 Mg (40 Kg – 56 Kg) | Giant and extra-large breeds (e.g., Mastiffs, Great Danes, Rottweilers). |
*Note: For dogs weighing over 56 kg (123 lbs), administer an appropriate combination of two chewable tablets that most accurately matches total body weight.
Administration Rules: Maximizing Bioavailability
To guarantee that the single dose delivers a full 12 weeks of coverage, proper administration technique is essential:
- Administer with Food: Bravecto chewable tablets must be given with or around the time of feeding. Dietary fat and gastric chyme significantly enhance systemic absorption, ensuring peak bio-availability.
- Do Not Split or Break Tablets: The active Fluralaner is uniformly dispersed, but splitting chewables can lead to inaccurate dosing. Always choose the exact whole tablet strength for your dog’s weight.
- Minimum Age and Weight Threshold: Safe for puppies and dogs 6 months of age and older weighing at least 2 kg (4.4 lbs).
Safety Profile & Adverse Reactions
Bravecto has a wide safety margin in healthy canines (tested safely up to 5 times the clinical dose in breeding, pregnant, and lactating dogs, as well as MDR1-deficient Collies):
Monitoring and Precautions
1. Common Transient Side Effects: Mild gastrointestinal effects (such as transient vomiting, decreased appetite, diarrhea, or lethargy) affect a small percentage of pets shortly after ingestion.
2. Isoxazoline Neurologic Precaution: Like all isoxazoline medications, Fluralaner carries potential risks of muscle tremors, ataxia, and seizures. Use with caution in pets with pre-existing seizure disorders.
For a deep dive into official peer-reviewed chemical structures, pharmacokinetics, and molecular safety assays for Fluralaner, consult the National Center for Biotechnology Information (NCBI) PubChem Database.
For official international veterinary health guidance and vector-borne zoonotic disease management standards, visit the official World Health Organization (WHO) Zoonoses Directory.
Bravecto Treatment Safety Checklist
Keep these core clinical guidelines in mind when administering long-acting flea and tick protection:
- ✔️ Confirm Your Dog’s Current Weight: Weigh your dog accurately to select the correct chewable strength tier.
- ✔️ Always Give with a Meal: Offer the chewable tablet with food to maximize gastrointestinal absorption.
- ✔️ Mark the 12-Week Calendar: Set a reminder for the next dose 84 days (12 weeks) later to eliminate protection gaps.
- ✔️ Note Local Lone Star Tick Prevalence: Consult your veterinarian if lone star ticks are common in your region, as redosing may be required at 8 weeks for that species.
- ✔️ Review Seizure History: Inform your veterinarian if your pet has any history of neurological conditions or epilepsy before treatment.
